Skip to main content
Top
Published in: Virchows Archiv 1/2023

Open Access 14-10-2022 | Acute Lymphoblastic Leukemia | Brief Report

PAX5 P80R-mutated B-cell acute lymphoblastic leukemia with transformation to histiocytic sarcoma: clonal evolution assessment using NGS-based immunoglobulin clonality and mutation analysis

Authors: Leonie I. Kroeze, B. Scheijen, K. M. Hebeda, J. Rijntjes, J. A. C. W. Luijks, D. Evers, W. Hobo, P. J. T. A. Groenen, M. van den Brand

Published in: Virchows Archiv | Issue 1/2023

Login to get access

Abstract

Clonality assessment by the detection of immunoglobulin (IG) gene rearrangements is an important method to determine whether two concurrent or subsequent lymphoid malignancies in one patient are clonally related. Here, we report the detailed clonality analysis in a patient with a diagnosis of B-cell acute lymphoblastic leukemia (B-ALL) followed by a histiocytic sarcoma (HS), in which we were able to study clonal evolution by applying next generation sequencing (NGS) to identify IG rearrangements and gene mutations. Using the sequence information of the NGS-based IG clonality analysis, multiple related subclones could be distinguished in the PAX5 P80R-mutated B-ALL. Notably, only one of these subclones evolved into HS after acquiring a RAF1 mutation. This case demonstrates that NGS-based IG clonality assessment and mutation analysis provide clear added value for clonal comparison and thereby improves clinicobiological understanding.
Appendix
Available only for authorised users
Literature
1.
go back to reference van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98–3936. Leukemia 17:2257–2317. https://doi.org/10.1038/sj.leu.2403202CrossRefPubMed van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98–3936. Leukemia 17:2257–2317. https://​doi.​org/​10.​1038/​sj.​leu.​2403202CrossRefPubMed
2.
go back to reference Scheijen B, Meijers RWJ, Rijntjes J, van der Klift MY, Mobs M, Steinhilber J, Reigl T, van den Brand M, Kotrova M, Ritter JM, Catherwood MA, Stamatopoulos K, Bruggemann M, Davi F, Darzentas N, Pott C, Fend F, Hummel M, Langerak AW, Groenen P, EuroClonality NGSWG (2019) Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS. Leukemia 33:2227–2240. https://doi.org/10.1038/s41375-019-0508-7CrossRefPubMedPubMedCentral Scheijen B, Meijers RWJ, Rijntjes J, van der Klift MY, Mobs M, Steinhilber J, Reigl T, van den Brand M, Kotrova M, Ritter JM, Catherwood MA, Stamatopoulos K, Bruggemann M, Davi F, Darzentas N, Pott C, Fend F, Hummel M, Langerak AW, Groenen P, EuroClonality NGSWG (2019) Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS. Leukemia 33:2227–2240. https://​doi.​org/​10.​1038/​s41375-019-0508-7CrossRefPubMedPubMedCentral
3.
go back to reference Kroeze LI, de Voer RM, Kamping EJ, von Rhein D, Jansen EAM, Hermsen MJW, Barberis MCP, Botling J, Garrido-Martin EM, Haller F, Lacroix L, Maes B, Merkelbach-Bruse S, Pestinger V, Pfarr N, Stenzinger A, van den Heuvel MM, Grunberg K, Ligtenberg MJL (2020) Evaluation of a hybrid capture-based pan-cancer panel for analysis of treatment stratifying oncogenic aberrations and processes. J Mol Diagn 22:757–769. https://doi.org/10.1016/j.jmoldx.2020.02.009CrossRefPubMed Kroeze LI, de Voer RM, Kamping EJ, von Rhein D, Jansen EAM, Hermsen MJW, Barberis MCP, Botling J, Garrido-Martin EM, Haller F, Lacroix L, Maes B, Merkelbach-Bruse S, Pestinger V, Pfarr N, Stenzinger A, van den Heuvel MM, Grunberg K, Ligtenberg MJL (2020) Evaluation of a hybrid capture-based pan-cancer panel for analysis of treatment stratifying oncogenic aberrations and processes. J Mol Diagn 22:757–769. https://​doi.​org/​10.​1016/​j.​jmoldx.​2020.​02.​009CrossRefPubMed
4.
go back to reference van den Brand M, Rijntjes J, Mobs M, Steinhilber J, van der Klift MY, Heezen KC, Kroeze LI, Reigl T, Porc J, Darzentas N, Luijks J, Scheijen B, Davi F, ElDaly H, Liu H, Anagnostopoulos I, Hummel M, Fend F, Langerak AW, Groenen P, EuroClonality NGSWG (2021) Next-generation sequencing-based clonality assessment of Ig gene rearrangements: a multicenter validation study by EuroClonality-NGS. J Mol Diagn 23:1105–1115. https://doi.org/10.1016/j.jmoldx.2021.06.005CrossRefPubMed van den Brand M, Rijntjes J, Mobs M, Steinhilber J, van der Klift MY, Heezen KC, Kroeze LI, Reigl T, Porc J, Darzentas N, Luijks J, Scheijen B, Davi F, ElDaly H, Liu H, Anagnostopoulos I, Hummel M, Fend F, Langerak AW, Groenen P, EuroClonality NGSWG (2021) Next-generation sequencing-based clonality assessment of Ig gene rearrangements: a multicenter validation study by EuroClonality-NGS. J Mol Diagn 23:1105–1115. https://​doi.​org/​10.​1016/​j.​jmoldx.​2021.​06.​005CrossRefPubMed
5.
go back to reference Passet M, Boissel N, Sigaux F, Saillard C, Bargetzi M, Ba I, Thomas X, Graux C, Chalandon Y, Leguay T, Lengline E, Konopacki J, Quentin S, Delabesse E, Lafage-Pochitaloff M, Pastoret C, Grardel N, Asnafi V, Lheritier V, Soulier J, Dombret H, Clappier E, Group for Research on Adult ALL (2019) PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome. Blood 133:280–284. https://doi.org/10.1182/blood-2018-10-882142CrossRefPubMed Passet M, Boissel N, Sigaux F, Saillard C, Bargetzi M, Ba I, Thomas X, Graux C, Chalandon Y, Leguay T, Lengline E, Konopacki J, Quentin S, Delabesse E, Lafage-Pochitaloff M, Pastoret C, Grardel N, Asnafi V, Lheritier V, Soulier J, Dombret H, Clappier E, Group for Research on Adult ALL (2019) PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome. Blood 133:280–284. https://​doi.​org/​10.​1182/​blood-2018-10-882142CrossRefPubMed
6.
go back to reference Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, Hagiwara K, Pelletier S, Gingras S, Berns H, Payne-Turner D, Hill A, Iacobucci I, Shi L, Pounds S, Cheng C, Pei D, Qu C, Newman S, Devidas M, Dai Y, Reshmi SC, Gastier-Foster J, Raetz EA, Borowitz MJ, Wood BL, Carroll WL, Zweidler-McKay PA, Rabin KR, Mattano LA, Maloney KW, Rambaldi A, Spinelli O, Radich JP, Minden MD, Rowe JM, Luger S, Litzow MR, Tallman MS, Racevskis J, Zhang Y, Bhatia R, Kohlschmidt J, Mrozek K, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Evans WE, Jeha S, Pui CH, Yang J, Paietta E, Downing JR, Relling MV, Zhang J, Loh ML, Hunger SP, Mullighan CG (2019) PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet 51:296–307. https://doi.org/10.1038/s41588-018-0315-5CrossRefPubMedPubMedCentral Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, Hagiwara K, Pelletier S, Gingras S, Berns H, Payne-Turner D, Hill A, Iacobucci I, Shi L, Pounds S, Cheng C, Pei D, Qu C, Newman S, Devidas M, Dai Y, Reshmi SC, Gastier-Foster J, Raetz EA, Borowitz MJ, Wood BL, Carroll WL, Zweidler-McKay PA, Rabin KR, Mattano LA, Maloney KW, Rambaldi A, Spinelli O, Radich JP, Minden MD, Rowe JM, Luger S, Litzow MR, Tallman MS, Racevskis J, Zhang Y, Bhatia R, Kohlschmidt J, Mrozek K, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Evans WE, Jeha S, Pui CH, Yang J, Paietta E, Downing JR, Relling MV, Zhang J, Loh ML, Hunger SP, Mullighan CG (2019) PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet 51:296–307. https://​doi.​org/​10.​1038/​s41588-018-0315-5CrossRefPubMedPubMedCentral
9.
go back to reference Kemps PG, Hebeda KM, Pals ST, Verdijk RM, Lam KH, Bruggink AH, de Lil HS, Ruiterkamp B, de Heer K, van Laar JA, Valk PJ, Mutsaers P, Levin MD, Hogendoorn PC, van Halteren AG (2021) Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation J Pathol. Clin Res 7:10–26. https://doi.org/10.1002/cjp2.177CrossRef Kemps PG, Hebeda KM, Pals ST, Verdijk RM, Lam KH, Bruggink AH, de Lil HS, Ruiterkamp B, de Heer K, van Laar JA, Valk PJ, Mutsaers P, Levin MD, Hogendoorn PC, van Halteren AG (2021) Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation J Pathol. Clin Res 7:10–26. https://​doi.​org/​10.​1002/​cjp2.​177CrossRef
10.
go back to reference Pericart S, Waysse C, Siegfried A, Struski S, Delabesse E, Laurent C, Evrard S (2020) Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature. Virchows Arch 476:609–614. https://doi.org/10.1007/s00428-019-02691-wCrossRefPubMed Pericart S, Waysse C, Siegfried A, Struski S, Delabesse E, Laurent C, Evrard S (2020) Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature. Virchows Arch 476:609–614. https://​doi.​org/​10.​1007/​s00428-019-02691-wCrossRefPubMed
11.
13.
go back to reference Pagni F, Fazio G, Zannella S, Spinelli M, De Angelis C, Cusi C, Crosti F, Corral L, Bugarin C, Biondi A, Cazzaniga G, Isimbaldi G, Cattoretti G (2014) The role of PAX5 and C/EBP alpha/beta in atypical non-Langerhans cell histiocytic tumor post acute lymphoblastic leukemia. Leukemia 28:1377–1379. https://doi.org/10.1038/leu.2014.87CrossRefPubMed Pagni F, Fazio G, Zannella S, Spinelli M, De Angelis C, Cusi C, Crosti F, Corral L, Bugarin C, Biondi A, Cazzaniga G, Isimbaldi G, Cattoretti G (2014) The role of PAX5 and C/EBP alpha/beta in atypical non-Langerhans cell histiocytic tumor post acute lymphoblastic leukemia. Leukemia 28:1377–1379. https://​doi.​org/​10.​1038/​leu.​2014.​87CrossRefPubMed
14.
go back to reference Novakova M, Zaliova M, Fiser K, Vakrmanova B, Slamova L, Musilova A, Bruggemann M, Ritgen M, Fronkova E, Kalina T, Stary J, Winkowska L, Svec P, Kolenova A, Stuchly J, Zuna J, Trka J, Hrusak O, Mejstrikova E (2021) DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch. Haematologica 106:2066–2075. https://doi.org/10.3324/haematol.2020.250423CrossRefPubMed Novakova M, Zaliova M, Fiser K, Vakrmanova B, Slamova L, Musilova A, Bruggemann M, Ritgen M, Fronkova E, Kalina T, Stary J, Winkowska L, Svec P, Kolenova A, Stuchly J, Zuna J, Trka J, Hrusak O, Mejstrikova E (2021) DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch. Haematologica 106:2066–2075. https://​doi.​org/​10.​3324/​haematol.​2020.​250423CrossRefPubMed
Metadata
Title
PAX5 P80R-mutated B-cell acute lymphoblastic leukemia with transformation to histiocytic sarcoma: clonal evolution assessment using NGS-based immunoglobulin clonality and mutation analysis
Authors
Leonie I. Kroeze
B. Scheijen
K. M. Hebeda
J. Rijntjes
J. A. C. W. Luijks
D. Evers
W. Hobo
P. J. T. A. Groenen
M. van den Brand
Publication date
14-10-2022
Publisher
Springer Berlin Heidelberg
Published in
Virchows Archiv / Issue 1/2023
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-022-03428-y

Other articles of this Issue 1/2023

Virchows Archiv 1/2023 Go to the issue